Epidemiological associations of allergy, IgE and cancer

Clinical and Experimental Allergy

Volumn 43, Issue 10, 2013, Pages 1110-1123

  Josephs, D H ^a,b   Spicer, J F ^b   Corrigan, C J ^c   Gould, H J ^c   Karagiannis, S N ^a  

^a BHF Centre for Regenerative Medicine and BHF Centre of Excellence and the Biomedical Research Centre at Guy s St Thomas NHS Foundation Trust and King s College London   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E ANTIBODY;

ALLERGY; BLADDER CANCER; BRAIN TUMOR; CANCER RISK; CHRONIC INFLAMMATION; COLORECTAL CANCER; DISEASE ASSOCIATION; ENDOMETRIUM CANCER; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSURVEILLANCE; LUNG CANCER; MALIGNANT NEOPLASTIC DISEASE; NON MELANOMA SKIN CANCER; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL; PROPHYLAXIS; PROSTATE CANCER; REVIEW; RISK ASSESSMENT; SKIN CANCER; STOMACH CANCER; TH2 CELL;

CELL TRANSFORMATION, NEOPLASTIC; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; NEOPLASMS; RISK;

EID: 84884680731     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12178     Document Type: Review

References (100)

1. Sherman PW, Holland E, Sherman JS. Allergies: their role in cancer prevention. Q Rev Biol 2008; 83:339-62.
2. Heikkila K, Harris R, Lowe G et al. Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis. Cancer Causes Control 2009; 20:15-26.
3. Siemes C, Visser LE, Coebergh JW et al. C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study. J Clin Oncol 2006; 24:5216-22.
4. Profet M. The function of allergy: immunological defense against toxins. Q Rev Biol 1991; 66:23-62.
5. Van Hemelrijck M, Garmo H, Binda E et al. Immunoglobulin E and cancer: a meta-analysis and a large Swedish cohort study. Cancer Causes Control 2010; 21:1657-67.
6. Turner MC. Epidemiologicl evidence: IgE and solid tumours. In: Penichet ML, Jensen-Jarolim E, eds. Cancer and IgE: introducing the concept of allergoOncology. New York: Springer, 2010:47-77.
7. Mills PK, Beeson WL, Fraser GE, Phillips RL. Allergy and cancer: organ site-specific results from the Adventist Health Study. Am J Epidemiol 1992; 136:287-95.
8. Knuiman MW, James AL, Divitini ML, Ryan G, Bartholomew HC, Musk AW. Lung function, respiratory symptoms, and mortality: results from the Busselton Health Study. Ann Epidemiol 1999; 9:297-306.
9. Lange P, Ulrik CS, Vestbo J. Mortality in adults with self-reported asthma. Copenhagen City Heart Study Group. Lancet 1996; 347:1285-9.
10. Vandentorren S, Baldi I, Annesi Maesano I et al. Long-term mortality among adults with or without asthma in the PAARC study. Eur Respir J 2003; 21:462-7.
11. Turner MC, Chen Y, Krewski D, Ghadirian P, Thun MJ, Calle EE. Cancer mortality among US men and women with asthma and hay fever. Am J Epidemiol 2005; 162:212-21.
12. Hagstromer L, Ye W, Nyren O, Emtestam L. Incidence of cancer among patients with atopic dermatitis. Arch Dermatol 2005; 141:1123-7.
13. Kallen B, Gunnarskog J, Conradson TB. Cancer risk in asthmatic subjects selected from hospital discharge registry. Eur Respir J 1993; 6:694-7.
14. Margolis D, Bilker W, Hennessy S, Vittorio C, Santanna J, Strom BL. The risk of malignancy associated with psoriasis. Arch Dermatol 2001; 137:778-83.
15. Olesen AB, Engholm G, Storm HH, Thestrup-Pedersen K. The risk of cancer among patients previously hospitalized for atopic dermatitis. J Invest Dermatol 2005; 125:445-9.
16. Vesterinen E, Pukkala E, Timonen T, Aromaa A. Cancer incidence among 78, 000 asthmatic patients. Int J Epidemiol 1993; 22:976-82.
17. Ji J, Shu X, Li X, Sundquist K, Sundquist J, Hemminki K. Cancer risk in hospitalised asthma patients. Br J Cancer 2009; 100:829-33.
18. Arana A, Wentworth CE, Fernandez-Vidaurre C, Schlienger RG, Conde E, Arellano FM. Incidence of cancer in the general population and in patients with or without atopic dermatitis in the U.K. Br J Dermatol 2010; 163:1036-43.
19. Lindelof B, Granath F, Tengvall-Linder M, Ekbom A. Allergy and cancer. Allergy 2005; 60:1116-20.
20. Eriksson NE, Mikoczy Z, Hagmar L. Cancer incidence in 13811 patients skin tested for allergy. J Investig Allergol Clin Immunol 2005; 15:161-6.
21. Gergen PJ, Turkeltaub PC, Sempos CT. Is allergen skin test reactivity a predictor of mortality? Findings from a national cohort. Clinical Exp Allergy 2000; 30:1717-23.
22. Gandini S, Lowenfels AB, Jaffee EM, Armstrong TD, Maisonneuve P. Allergies and the risk of pancreatic cancer: a meta-analysis with review of epidemiology and biological mechanisms. Cancer Epidemiol Biomarkers Prev 2005; 14:1908-16.
23. Eppel A, Cotterchio M, Gallinger S. Allergies are associated with reduced pancreas cancer risk: a population-based case-control study in Ontario, Canada. Int J Cancer 2007; 121:2241-5.
24. Olson SH, Orlow I, Simon J et al. Allergies, variants in IL-4 and IL-4R alpha genes, and risk of pancreatic cancer. Cancer Detect Prev 2007; 31:345-51.
25. Olson SH, Chou JF, Ludwig E et al. Allergies, obesity, other risk factors and survival from pancreatic cancer. Int J Cancer 2010; 127:2412-9.
26. Linos E, Raine T, Alonso A, Michaud D. Atopy and risk of brain tumors: a meta-analysis. J Natl Cancer Inst 2007; 99:1544-50.
27. Wigertz A, Lonn S, Schwartzbaum J et al. Allergic conditions and brain tumor risk. Am J Epidemiol 2007; 166:941-50.
28. Claus EB, Calvocoressi L, Bondy ML, Schildkraut JM, Wiemels JL, Wrensch M. Family and personal medical history and risk of meningioma. J Neurosurg 2011; 115:1072-7.
29. McCarthy BJ, Rankin K, Il'yasova D et al. Assessment of type of allergy and antihistamine use in the development of glioma. Cancer Epidemiol Biomarkers Prev 2011; 20:370-8.
30. Turner MC, Krewski D, Armstrong BK et al. Allergy and brain tumors in the INTERPHONE study: pooled results from Australia, Canada, France, Israel, and New Zealand. Cancer Causes Control 2013; 24:949-60.
31. Wiemels JL, Wrensch M, Sison JD et al. Reduced allergy and immunoglobulin E among adults with intracranial meningioma compared to controls. Int J Cancer 2011; 129:1932-9.
32. Wiemels JL, Wiencke JK, Patoka J et al. Reduced immunoglobulin E and allergy among adults with glioma compared with controls. Cancer Res 2004; 64:8468-73.
33. Wiemels JL, Wilson D, Patil C et al. IgE, allergy, and risk of glioma: update from the San Francisco Bay Area Adult Glioma Study in the temozolomide era. Int J Cancer 2009; 125:680-7.
34. Wrensch M, Wiencke JK, Wiemels J et al. Serum IgE, tumor epidermal growth factor receptor expression, and inherited polymorphisms associated with glioma survival. Cancer Res 2006; 66:4531-41.
35. Becker N, de Sanjose S, Nieters A et al. Birth order, allergies and lymphoma risk: results of the European collaborative research project Epilymph. Leuk Res 2007; 31:1365-72.
36. Mirabelli MC, Zock JP, D'Errico A et al. Occupational exposure to high molecular weight allergens and lymphoma risk among Italian adults. Cancer Epidemiol Biomarkers Prev 2009; 18:2650-4.
37. Vajdic CM, Falster MO, de Sanjose S et al. Atopic disease and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis. Cancer Res 2009; 69:6482-9.
38. Ellison-Loschmann L, Benavente Y, Douwes J et al. Immunoglobulin E levels and risk of lymphoma in a case-control study in Spain. Cancer Epidemiol Biomarkers Prev 2007; 16:1492-8.
39. Melbye M, Smedby KE, Lehtinen T et al. Atopy and risk of non-Hodgkin lymphoma. J Natl Cancer Inst 2007; 99:158-66.
40. Soderberg KC, Hagmar L, Schwartzbaum J, Feychting M. Allergic conditions and risk of hematological malignancies in adults: a cohort study. BMC Public Health 2004; 4:51.
41. Soderberg KC, Jonsson F, Winqvist O, Hagmar L, Feychting M. Autoimmune diseases, asthma and risk of haematological malignancies: a nationwide case-control study in Sweden. Eur J Cancer 2006; 42:3028-33.
42. Jourdan-Da Silva N, Perel Y, Mechinaud F et al. Infectious diseases in the first year of life, perinatal characteristics and childhood acute leukaemia. Br J Cancer 2004; 90:139-45.
43. Wen W, Shu XO, Linet MS et al. Allergic disorders and the risk of childhood acute lymphoblastic leukaemia (United States). Cancer Causes Control 2000; 11:303-7.
44. Nishi M, Miyake H. A case-control study of non-T cell acute lymphoblastic leukaemia of children in Hokkaido, Japan. J Epidemiol Community Health 1989; 43:352-5.
45. Petridou E, Trichopoulos D, Kalapothaki V et al. The risk profile of childhood leukaemia in Greece: a nationwide case-control study. Br J Cancer 1997; 76:1241-7.
46. Schuz J, Morgan G, Bohler E, Kaatsch P, Michaelis J. Atopic disease and childhood acute lymphoblastic leukaemia. Int J Cancer 2003; 105:255-60.
47. Spector L, Groves F, DeStefano F et al. Medically recorded allergies and the risk of childhood acute lymphoblastic leukaemia. Eur J Cancer 2004; 40:579-84.
48. Rosenbaum PF, Buck GM, Brecher ML. Allergy and infectious disease histories and the risk of childhood acute lymphoblastic leukaemia. Paediatr Perinat Epidemiol 2005; 19:152-64.
49. Hughes AM, Lightfoot T, Simpson J et al. Allergy and risk of childhood leukaemia: results from the UKCCS. Int J Cancer 2007; 121:819-24.
50. Linabery AM, Jurek AM, Duval S, Ross JA. The association between atopy and childhood/adolescent leukaemia: a meta-analysis. Am J Epidemiol 2010; 171:749-64.
51. Rudant J, Orsi L, Menegaux F et al. Childhood acute leukaemia, early common infections, and allergy: The ESCALE Study. Am J Epidemiol 2010; 172:1015-27.
52. Nunez-Enriquez JC, Fajardo-Gutierrez A, Buchan-Duran EP et al. Allergy and acute leukaemia in children with Down syndrome: a population study. Report from the Mexican inter-institutional group for the identification of the causes of childhood leukaemia. Br J Cancer 2013; 108:2334-8.
53. Bosetti C, Talamini R, Franceschi S, Negri E, Giacosa A, La Vecchia C. Allergy and the risk of selected digestive and laryngeal neoplasms. Eur J Cancer Prev 2004; 13:173-6.
54. Prizment AE, Folsom AR, Cerhan JR, Flood A, Ross JA, Anderson KE. History of allergy and reduced incidence of colorectal cancer, Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev 2007; 16:2357-62.
55. Vena JE, Bona JR, Byers TE, Middleton E Jr, Swanson MK, Graham S. Allergy-related diseases and cancer: an inverse association. Am J Epidemiol 1985; 122:66-74.
56. Vobecky J, Caro J, Devroede G. A case-control study of risk factors for large bowel carcinoma. Cancer 1983; 51:1958-63.
57. Wang H, Rothenbacher D, Low M, Stegmaier C, Brenner H, Diepgen TL. Atopic diseases, immunoglobulin E and risk of cancer of the prostate, breast, lung and colorectum. Int J Cancer 2006; 119:695-701.
58. El-Zein M, Parent ME, Ka K, Siemiatycki J, St-Pierre Y, Rousseau MC. History of asthma or eczema and cancer risk among men: a population-based case-control study in Montreal, Quebec, Canada. Ann Allergy Asthma Immunol 2010; 104:378-84.
59. Hwang CY, Chen YJ, Lin MW et al. Cancer risk in patients with allergic rhinitis, asthma and atopic dermatitis: a nationwide cohort study in Taiwan. Int J Cancer 2012; 130:1160-7.
60. Gonzalez-Perez A, Fernandez-Vidaurre C, Rueda A, Rivero E, Garcia Rodriguez LA. Cancer incidence in a general population of asthma patients. Pharmacoepidemiol Drug Saf 2006; 15:131-8.
61. Elmasri WM, Tran TH, Mulla ZD. A case-control study of asthma and ovarian cancer. Arch Environ Occup Health 2010; 65:101-5.
62. Johnson LG, Schwartz SM, Malkki M et al. Risk of cervical cancer associated with allergies and polymorphisms in genes in the chromosome 5 cytokine cluster. Cancer Epidemiol Biomarkers Prev 2011; 20:199-207.
63. Huovinen E, Kaprio J, Vesterinen E, Koskenvuo M. Mortality of adults with asthma: a prospective cohort study. Thorax 1997; 52:49-54.
64. Mayne ST, Buenconsejo J, Janerich DT. Previous lung disease and risk of lung cancer among men and women nonsmokers. Am J Epidemiol 1999; 149:13-20.
65. Boffetta P, Ye W, Boman G, Nyren O. Lung cancer risk in a population-based cohort of patients hospitalized for asthma in Sweden. Eur Respir J 2002; 19:127-33.
66. Fan YG, Jiang Y, Chang RS et al. Prior lung disease and lung cancer risk in an occupational-based cohort in Yunnan, China. Lung Cancer 2011; 72:258-63.
67. Wang XR, Yu IT, Chiu YL et al. Previous pulmonary disease and family cancer history increase the risk of lung cancer among Hong Kong women. Cancer Causes Control 2009; 20:757-63.
68. Koh WP, Yuan JM, Wang R, Seow A, Lee HP, Yu MC. Chronic rhinosinusitis and risk of lung cancer in the Singapore Chinese Health Study. Int J Cancer 2008; 123:1398-402.
69. Lim WY, Chen Y, Ali SM et al. Polymorphisms in inflammatory pathway genes, host factors and lung cancer risk in Chinese female never-smokers. Carcinogenesis 2011; 32:522-9.
70. Kolmel KF, Compagnone D. Melanoma and atopy. Dtsch Med Wochenschr 1988; 113:169-71.
71. Talbot-Smith A, Fritschi L, Divitini ML, Mallon DF, Knuiman MW. Allergy, atopy, and cancer: a prospective study of the 1981 Busselton cohort. Am J Epidemiol 2003; 157:606-12.
72. Wiemels JL, Wiencke JK, Li Z, Ramos C, Nelson HH, Karagas MR. Risk of squamous cell carcinoma of the skin in relation to IgE: a nested case-control study. Cancer Epidemiol Biomarkers Prev 2011; 20:2377-83.
73. Pelucchi C, Naldi L, Di Landro A, La Vecchia C. Anthropometric measures, medical history and risk of basal cell carcinoma in an Italian case-control study. Dermatology 2008; 216:271-6.
74. Ming ME, Levy R, Hoffstad O et al. The lack of a relationship between atopic dermatitis and nonmelanoma skin cancers. J Am Acad Dermatol 2004; 50:357-62.
75. Steineck G, Adolfsson J, Scher HI, Whitmore WF Jr. Distinguishing prognostic and treatment-predictive information for localized prostate cancer. Urology 1995; 45:610-5.
76. Kim WJ, Lee HL, Lee SC, Kim YT, Kim H. Polymorphisms of N-acetyltransferase 2, glutathione S-transferase mu and theta genes as risk factors of bladder cancer in relation to asthma and tuberculosis. J Urol 2000; 164:209-13.
77. Calboli FC, Cox DG, Buring JE et al. Prediagnostic plasma IgE levels and risk of adult glioma in four prospective cohort studies. J Natl Cancer Inst 2011; 103:1588-95.
78. Schwartzbaum J, Ding B, Johannesen TB et al. Association between prediagnostic IgE levels and risk of glioma. J Natl Cancer Inst 2012; 104:1251-9.
79. Carosso A, Bugiani M, Migliore E, Anto JM, DeMarco R. Reference values of total serum IgE and their significance in the diagnosis of allergy in young European adults. Int Arch Allergy Immunol 2007; 142:230-8.
80. Hoppin JA, Jaramillo R, Salo P, Sandler DP, London SJ, Zeldin DC. Questionnaire predictors of atopy in a US population sample: findings from the National Health and Nutrition Examination Survey, 2005-2006. Am J Epidemiol 2011; 173:544-52.
81. Schabath MB, Gorlova OY, Spitz MR. Re: "Cancer mortality among US men and women with asthma and hay fever". Am J Epidemiol 2006; 163:394-5; author reply 95-6.
82. Turner MC. Epidemiology: allergy history, IgE, and cancer. Cancer Immunol Immunother 2012; 61:1493-510.
83. Karagiannis SN, Wang Q, East N et al. Activity of human monocytes in IgE antibody-dependent surveillance and killing of ovarian tumor cells. Eur J Immunol 2003; 33:1030-40.
84. Karagiannis SN, Bracher MG, Hunt J et al. IgE-antibody-dependent immunotherapy of solid tumors: cytotoxic and phagocytic mechanisms of eradication of ovarian cancer cells. J Immunol 2007; 179:2832-43.
85. Karagiannis SN, Bracher MG, Beavil RL et al. Role of IgE receptors in IgE antibody-dependent cytotoxicity and phagocytosis of ovarian tumor cells by human monocytic cells. Cancer Immunol Immunother 2008; 57:247-63.
86. Karagiannis SN, Nestle FO, Gould HJ. IgE interacts with potent effector cells against tumors: ADCC and ADCP. In: Penichet ML, Jensen-Jarolim E, eds. Cancer and IgE: introducing the concept of allergoOncology. New York: Humana Press, Springer, ISBN: 978-1-60761-450-0, Chapter 8, 2010:185-213.
87. Karagiannis SN, Josephs DH, Karagiannis P et al. Recombinant IgE antibodies for passive immunotherapy of solid tumours: from concept towards clinical application. Cancer Immunol Immunother 2012; 61:1547-64.
88. Finkelman FD, Urban JF Jr. The other side of the coin: the protective role of the TH2 cytokines. J Allergy Clin Immunol 2001; 107:772-80.
89. Mantovani A, Biswas SK, Galdiero MR, Sica A, Locati M. Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol 2013; 229:176-85.
90. Dalton DK, Noelle RJ. The roles of mast cells in anticancer immunity. Cancer Immunol Immunother 2012; 61:1511-20.
91. Ruffell B, Affara NI, Coussens LM. Differential macrophage programming in the tumor microenvironment. Trends Immunol 2012; 33:119-26.
92. Karagiannis P, Gilbert AE, Josephs DH et al. IgG4 subclass antibodies impair antitumor immunity in melanoma. J Clin Investig 2013; 123:1457-74.
93. Krop EJ, Stapel SO, De Vrieze H, Van der Zee JS. Immunoglobulin E and G4 antibody responses in occupational airway exposure to bovine and porcine plasma proteins. Int Arch Allergy Immunol 2006; 139:237-44.
94. Matsui EC, Diette GB, Krop EJ et al. Mouse allergen-specific immunoglobulin G and immunoglobulin G4 and allergic symptoms in immunoglobulin E-sensitized laboratory animal workers. Clinical Exp Allergy 2005; 35:1347-53.
95. Harada K, Shimoda S, Kimura Y et al. Significance of immunoglobulin G4 (IgG4)-positive cells in extrahepatic cholangiocarcinoma: molecular mechanism of IgG4 reaction in cancer tissue. Hepatology 2012; 56:157-64.
96. Ghazale A, Chari ST, Smyrk TC et al. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol 2007; 102:1646-53.
97. Strid J, Sobolev O, Zafirova B, Polic B, Hayday A. The intraepithelial T cell response to NKG2D-ligands links lymphoid stress surveillance to atopy. Science 2011; 334:1293-7.
98. Jensen-Jarolim E, Achatz G, Turner MC et al. AllergoOncology: the role of IgE-mediated allergy in cancer. Allergy 2008; 63:1255-66.
99. Jensen-Jarolim E, Pawelec G. The nascent field of AllergoOncology. Cancer Immunol Immunother 2012; 61:1355-7.
100. Penichet ML, Jensen-Jarolim E. Cancer and IgE: introducing the concept of allergoOncology. New York: Humana Press, 2010.